Dov Elefant
Insider
First SEC filing: Jan. 2, 2015 · Latest: Jan. 2, 2015
Insider at
Insider transactions
1 buys (P)
0 sells (S)
Net: $50,000
Avg return of open purchases vs now: -36.9%
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | FEMY | P | 15,625 | $3.20 | $50,000 | 15,625 Direct | · | Acquired | -36.9% (price as of 2026-10-05) |
| Aug. 7, 2026 | FEMY | A | 15,625 | · | · | 15,625 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 7, 2026 | FEMY | A | 15,625 | · | · | 15,625 Direct | · | Acquired | (price as of 2026-10-05) |
| March 19, 2026 | FEMY | A | 34,122 | · | · | 34,122 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 19, 2026 | FEMY | A | 169,000 | · | · | 169,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 19, 2026 | FEMY | A | 173,000 | · | · | 173,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 7, 2025 | FEMY | I | 34,122 | · | · | 34,122 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 7, 2025 | FEMY | I | 34,122 | · | · | 34,122 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 7, 2025 | FEMY | I | 34,122 | · | · | 34,122 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 7, 2025 | FEMY | I | None | · | · | · Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 27, 2025 | FEMY | I | 38,828 | · | · | 38,828 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 27, 2025 | FEMY | I | 38,828 | · | · | 58,436 Direct | +198.02% | Acquired | (price as of 2026-10-05) |
| June 2, 2025 | FEMY | I | 19,608 | $1.02 | $20,000 | 19,608 Direct | · | Acquired | -90.1% (price as of 2026-10-05) |
| Jan. 28, 2025 | FEMY | A | 114,300 | · | · | 114,300 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 28, 2025 | FEMY | A | 72,045 | · | · | 72,045 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 1, 2024 | FEMY | A | 84,000 | · | · | 84,000 Direct | · | Acquired | (price as of 2026-10-05) |
| July 3, 2023 | FEMY | A | 204,700 | · | · | 204,700 Direct | · | Acquired | (price as of 2026-10-05) |
| July 3, 2023 | FEMY | A | 105,200 | · | · | 105,200 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 28, 2022 | FEMY | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 25, 2022 | CLRB | A | 422,000 | · | · | 422,000 Direct | · | Acquired | (price as of 2026-10-05) |
| March 4, 2021 | CLRB | A | 430,000 | · | · | 430,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 28, 2020 | CLRB | P | 7,407 | $1.35 | $9,999 | 11,755 Direct | +170.35% | Acquired | -99.6% (price as of 2026-10-05) |
| June 5, 2020 | CLRB | P | 2,174 | $0.01 | $22 | 2,174 Direct | · | Acquired | -44.3% (price as of 2026-10-05) |
| June 5, 2020 | CLRB | P | 4,348 | $1.14 | $4,957 | 4,348 Direct | · | Acquired | -99.5% (price as of 2026-10-05) |
| Feb. 3, 2020 | CLRB | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 3, 2020 | CLRB | A | 10,000 | $2.71 | $27,100 | 10,000 Direct | · | Acquired | -99.8% (price as of 2026-10-05) |
| Sept. 10, 2019 | CLRB | A | 90,000 | · | · | 90,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 21, 2015 | AKTX | A | 4,067,963 | · | · | 4,067,963 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | FEMY | Common Stock Purchase Warrant | Common stock, par value $0.001 per share | · | Aug. 10, 2029 | 15,625 | Acquired |
| Aug. 7, 2026 | FEMY | Common Stock Purchase Warrant (Milestone) | Common stock, par value $0.001 per share | · | · | 15,625 | Acquired |
| March 19, 2026 | FEMY | Series D-1 Warrants | Common stock, par value $0.001 per share | · | March 19, 2036 | 34,122 | Acquired |
| Feb. 19, 2026 | FEMY | Restricted Stock Units | Common Stock | · | · | 169,000 | Acquired |
| Feb. 19, 2026 | FEMY | Restricted Stock Units | Common Stock | · | · | 173,000 | Acquired |
| Nov. 7, 2025 | FEMY | Series C-1 Warrants | Common stock, par value $0.001 per share | · | Nov. 7, 2035 | 34,122 | Acquired |
| Nov. 7, 2025 | FEMY | Series B-1 Warrants | Common stock, par value $0.001 per share | · | Nov. 7, 2035 | 34,122 | Acquired |
| Nov. 7, 2025 | FEMY | Series A-1 Warrants | Common stock, par value $0.001 per share | · | Nov. 7, 2035 | 34,122 | Acquired |
| Nov. 7, 2025 | FEMY | Senior Secured Convertible Notes | Common stock, par value $0.001 per share | · | Nov. 7, 2035 | · | Acquired |
| Aug. 27, 2025 | FEMY | Common Warrants (right to buy) | Common Stock | $0.52 | Aug. 27, 2030 | 38,828 | Acquired |
| Jan. 28, 2025 | FEMY | Stock Option (Right to Buy) | Common Stock | $1.05 | Jan. 28, 2035 | 114,300 | Acquired |
| Jan. 28, 2025 | FEMY | Stock Option (Right to Buy) | Common Stock | $1.05 | Jan. 28, 2035 | 72,045 | Acquired |
| Feb. 1, 2024 | FEMY | Stock Option (Right to Buy) | Common Stock | $0.80 | Feb. 1, 2034 | 84,000 | Acquired |
| July 3, 2023 | FEMY | Stock Option (Right to Buy) | Common Stock | $0.49 | July 3, 2033 | 204,700 | Acquired |
| July 3, 2023 | FEMY | Stock Option (Right to Buy) | Common Stock | $0.49 | July 3, 2033 | 105,200 | Acquired |
| Feb. 28, 2022 | FEMY | Stock Option (Right to Buy) | Common Stock | $2.97 | Feb. 28, 2032 | 100,000 | Acquired |
| Jan. 25, 2022 | CLRB | Stock option (right to buy) | Common Stock | $0.55 | Jan. 25, 2032 | 422,000 | Acquired |
| March 4, 2021 | CLRB | Stock option (right to buy) | Common Stock | $1.74 | March 4, 2031 | 430,000 | Acquired |
| June 5, 2020 | CLRB | Series H Warrants | Common Stock | $1.21 | June 5, 2025 | 2,174 | Acquired |
| Feb. 3, 2020 | CLRB | Stock Option (right to buy) | Common Stock | $2.71 | Feb. 3, 2030 | 10,000 | Acquired |
| Sept. 10, 2019 | CLRB | Stock Option (right to buy) | Common Stock | $2.32 | Sept. 10, 2029 | 90,000 | Acquired |
| Sept. 21, 2015 | AKTX | Options to Purchase Ordinary Shares | Ordinary Shares | $0.32 | Sept. 21, 2025 | 4,067,963 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $356,895 | · | · | $395,600 | $85,655 | · | · | $838,150 |
| 2020 | $324,450 | $126,536 | · | $20,874 | · | · | · | $471,860 |
| 2019 | $97,500 | $57,788 | · | $157,149 | · | · | · | $312,437 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $432,600 | $97,335 | · | · | · | · | $64,429 | $743,252 |
| 2024 | $432,600 | $40,067 | · | · | · | · | $76,137 | $605,836 |
| 2023 | $420,000 | $151,200 | · | · | · | · | $23,940 | $716,224 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2015 | $200,000 | $37,500 | · | $857,879 | · | · | · | $1,095,379 |
| 2014 | $200,000 | · | · | $20,188 | · | · | · | $220,188 |
| 2013 | $163,472 | $50,000 | · | $25,120 | · | · | · | $238,592 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.